These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26769985)

  • 1. MORAL HAZARD IN HEALTH INSURANCE: DO DYNAMIC INCENTIVES MATTER?
    Aron-Dine A; Einav L; Finkelstein A; Cullen M
    Rev Econ Stat; 2015 Oct; 97(4):725-741. PubMed ID: 26769985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What to expect when you are expecting: Are health care consumers forward-looking?
    Guo A; Zhang J
    J Health Econ; 2019 Sep; 67():102216. PubMed ID: 31362142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disentangling Moral Hazard and Adverse Selection in Private Health Insurance.
    Powell D; Goldman D
    J Econom; 2021 May; 222(1):141-160. PubMed ID: 33716385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Employer contribution and premium growth in health insurance.
    Liu Y; Jin GZ
    J Health Econ; 2015 Jan; 39():228-47. PubMed ID: 25241905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insurance companies' point of view toward moral hazard incentives.
    Khorasani E; Keyvanara M; Etemadi M; Asadi S; Mohammadi M; Barati M
    J Med Ethics Hist Med; 2016; 9():12. PubMed ID: 28050242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A median voter model of health insurance with ex post moral hazard.
    Jacob J; Lundin D
    J Health Econ; 2005 Mar; 24(2):407-26. PubMed ID: 15721052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare Demand in the Presence of Discrete Price Changes.
    Gerfin M; Kaiser B; Schmid C
    Health Econ; 2015 Sep; 24(9):1164-77. PubMed ID: 25648329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three years in - changing plan features in the U.S. health insurance marketplace.
    McKillop CN; Waters TM; Kaplan CM; Kaplan EK; Thompson MP; Graetz I
    BMC Health Serv Res; 2018 Jun; 18(1):450. PubMed ID: 29902996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of health reform for retiree health benefits.
    Fronstin P
    EBRI Issue Brief; 2010 Jan; (338):1-17. PubMed ID: 20104796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moral Hazard and the Demand for Dental Treatment: Evidence from a Nationally Representative Survey in Thailand.
    Srimuang K; Pholphirul P
    Int J Dent; 2022; 2022():2259038. PubMed ID: 36034478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decomposition of moral hazard.
    Nyman JA; Koc C; Dowd BE; McCreedy E; Trenz HM
    J Health Econ; 2018 Jan; 57():168-178. PubMed ID: 29275240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric Information in Iranian's Health Insurance Market: Testing of Adverse Selection and Moral Hazard.
    Lotfi F; Abolghasem Gorji H; Mahdavi G; Hadian M
    Glob J Health Sci; 2015 Apr; 7(6):146-55. PubMed ID: 26153155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticipatory Behavior in Response to Medicare Part D's Coverage Gap.
    Kaplan CM; Zhang Y
    Health Econ; 2017 Mar; 26(3):338-351. PubMed ID: 26749399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Government and private insurance medical programs as well as MDVIP, an update.
    Edlich RF; Winters KL; Brit LD; Long WB
    J Long Term Eff Med Implants; 2004; 14(3):243-50. PubMed ID: 15301667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the Tradeoff Between Risk Protection and Moral Hazard with a Nonlinear Budget Set Model of Health Insurance.
    Kowalski AE
    Int J Ind Organ; 2015 Nov; 43():122-135. PubMed ID: 26664035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription Drug Use under Medicare Part D: A Linear Model of Nonlinear Budget Sets.
    Abaluck J; Gruber J; Swanson A
    J Public Econ; 2018 Aug; 164():106-138. PubMed ID: 30555190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilateral contracting and prevention.
    Pope B; Deshmukh A; Johnson A; Rohack J
    Health Econ; 2014 Apr; 23(4):397-409. PubMed ID: 23554156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplemental Health Insurance and Healthcare Consumption-A Dynamic Approach to Moral Hazard.
    Franc C; Perronnin M; Pierre A
    Health Econ; 2016 Dec; 25(12):1582-1598. PubMed ID: 26468078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which moral hazard? Health care reform under the Affordable Care Act of 2010.
    Mendoza RL
    J Health Organ Manag; 2016 Jun; 30(4):510-29. PubMed ID: 27296875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex-post moral hazard in the health insurance market: empirical evidence from German data.
    Thönnes S
    Eur J Health Econ; 2019 Dec; 20(9):1317-1333. PubMed ID: 31407102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.